Aarti Drugs Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "Press Release on Q3& 9M FY26 financial ".
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has notified the stock exchange about a press release dated February 3, 2026, covering its financial performance for the third quarter and nine months of FY26. The filing itself is a regulatory disclosure informing the market that detailed financial results have been published. The actual revenue, profit, and margin figures would be available in the referenced press release, not in this filing. This is a standard procedural announcement made ahead of or alongside the company's quarterly earnings update.
No direct price impact can be assessed from this filing alone, as it only confirms the release of a press release containing the financials. Investors should review the actual Q3 and 9M FY26 numbers in the press release to gauge the company's performance and any growth or margin trends.